Short Interest in Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) Expands By 6.8%

Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) was the target of a significant growth in short interest in June. As of June 15th, there was short interest totalling 45,500 shares, a growth of 6.8% from the May 31st total of 42,600 shares. Based on an average daily trading volume, of 7,200 shares, the days-to-cover ratio is currently 6.3 days.

Conduit Pharmaceuticals Stock Performance

Shares of NASDAQ CDTTW opened at $0.04 on Thursday. The stock’s 50-day moving average is $0.05 and its two-hundred day moving average is $0.06. Conduit Pharmaceuticals has a 1-year low of $0.01 and a 1-year high of $0.18.

Conduit Pharmaceuticals Company Profile

Conduit Pharmaceuticals Inc, a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility.